Advertisement

Pharmacy World and Science

, Volume 27, Issue 5, pp 376–384 | Cite as

Complex Pharmaceutical Care intervention in Pulmonary Care

Part A. The Process and Pharmacists’ Professional Satisfaction
  • Ada G. G. Stuurman-BiezeEmail author
  • Willem O. de Boer
  • Mirjam E. A. P. Kokenberg
  • Jacqueline G. Hugtenburg
  • Lolkje T. W. de Jong-van den Berg
  • Th. F. J. Tromp
Research Article

Abstract

Objective: In the IPMP study (Interventions on the principle of Pulmonary Medication Profiles), tailored pharmaceutical care interventions were provided to pulmonary patients selected because of drug use that deviates from Dutch guidelines. The aims were to solve drug-related problems and to improve patients’ drug use. This article describes the pharmaceutical care process tailored to the individual problems of patients in the intervention arm of a randomized controlled trial and defines the package of care.

Methods: After a preliminary selection of the patients with the help of the algorithmic IPMP computer instrument, instructed Dutch community pharmacists had structured consultations with patients (aged 13–70 years) in the intervention arm to identify behaviour and specific problems with their medication. Based on this identification process, a tailored intervention was constructed that could comprise one or more of six pharmaceutical care modules. Modules were clustered in sets describing the complete programme of care provided to one patient. If necessary, pharmacists consulted the patients’ physicians to improve the prescribed therapy. After the interventions, medication changes were evaluated with the patients. The prescribed medication and the refill rate were monitored in the pharmacy computer during 1 year. All activities and results were extensively monitored and documented.

Main outcome measure: Process description, i.e. number of provided pharmaceutical care modules and medication changes. Pharmacists’ satisfaction.

Results: Tailored interventions were provided to 199 patients at risk of sub-optimal drug therapy. In all 813 pharmaceutical care modules were performed and documented, and clustered in four different programmes. In addition to education and motivation to adhere to prescribed medication for all 199 patients, a medication change was suggested in 124 cases. Patients and physicians agreed upon a change in 94 cases. Device change was agreed upon in 58 of 64 cases, often simultaneously with medication change. Pharmacists consulted physicians concerning 100 patients. Pharmacists reported satisfaction with the pharmaceutical care approach.

Conclusion: Because of the extensive documentation, interventions could be described completely. Pharmacists observed a better drug use after educating patients or by solving their drug-related problems. In collaboration with physicians drug treatment could be improved.

Keywords

Asthma COPD Drug-related problems Guidelines Patient medication records Pharmaceutical care process Pharmacist satisfaction The Netherlands 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anonymous. Monitor zorg- en leefsituatie van mensen met astma en mensen met COPD (Monitor of care and living condition of asthma and COPD patients). Utrecht, The Netherlands: Nivel, 2003. ISBN 90-6905-615-1.Google Scholar
  2. 2.
    Anonymous. Global strategy for asthma management and prevention. NHLBI/WHO report. Bethesda, Maryland: National Institutes of Health, 1995.Google Scholar
  3. 3.
    Pauwels, RA, Buist, AS, Calverly, PMA,  et al. 2001Global strategy for the diagnosis, management, and prevention of chronic obstructive lung diseaseAm J Respir Crit Care Med163125676PubMedGoogle Scholar
  4. 4.
    Geijer, RMM, Hensbergen, W, Bottema, BJAM, Schayck, CP, Sachs, APE, Smeele, IJM,  et al. 2001NHG-Standaard Astma bij volwassenen: Behandeling (NHG Asthma standard for adults: treatment)Huisarts Wet4415364Google Scholar
  5. 5.
    Geijer, RMM, Schayck, CP, Weel, C, Sachs, APE, Bottema, BJAM, Smeele, IJM,  et al. 2001NHG-standaard COPD: behandeling (NHG COPD standard: treatment)Huisarts Wet4420719Google Scholar
  6. 6.
    Rabe, KF, Vermeire, PA, Soriano, JB, Maier, WC 2000Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) studyEur Respir J168027CrossRefPubMedGoogle Scholar
  7. 7.
    Hepler, CD, Strand, LM 1990Opportunities and responsibilities in pharmaceutical careAm J Hosp Pharm4753343PubMedGoogle Scholar
  8. 8.
    Narhi, U, Airaksinen, M, Tanskanen, P, Enlund, H 2001The effects of a pharmacy-based intervention on the knowledge and attitudes of asthma patientsPatient Educ Couns431717PubMedGoogle Scholar
  9. 9.
    Tullio, PL, Corson, ME 1987Effect of pharmacist counselling on ambulatory patients’ use of aerosolized bronchodilatorsAm J Hosp Pharm4418026PubMedGoogle Scholar
  10. 10.
    Diamond, SA, Chapman, KR 2001The impact of a nationally coordinated pharmacy-based asthma education interventionCan Respir J82615PubMedGoogle Scholar
  11. 11.
    Mil, JWF, Vander Graaf, CJ, Tromp, TFJ 1995Een keer is niet genoeg. De inhalatie-instructie (Once is not enough. The inhaler instruction)Pharm Weekbl130110311Google Scholar
  12. 12.
    Solomon, DK, Portner, TS, Bass, GE, Gourley, DR, Gourley, GA, Holt, JM,  et al. 1998Part 2. Clinical and economic outcomes in the hypertension and COPD Arms of a multicenter outcomes studyJ Am Pharm Assoc3857485Google Scholar
  13. 13.
    Herborg, H, Soendergaard, B, Froekjaer, B, Fonnesbaek, L, Jorgensen, T, Hepler, CD,  et al. 2001Improving drug therapy for patients with asthma – part 1: patient outcomesJ Am Pharm Assoc4153950Google Scholar
  14. 14.
    Herborg, H, Soendergaard, B, Jorgensen, T, Fonnesbaek, L, Hepler, CD, Holst, H,  et al. 2001Improving drug therapy for patients with asthma – part 2: Use of antiasthma medicationsJ Am Pharm Assoc415519Google Scholar
  15. 15.
    Van Mil JWF. Pharmaceutical Care: the Future of Pharmacy, Theory, Research and Practice [Dissertation]. Zuidlaren, The Netherlands: J.W.F. van Mil; 1999. ISBN 90-9013367-4.Google Scholar
  16. 16.
    Schulz, M, Verheyen, F, Muehlig, S, Mueller, JM, Muehlbauer, K, Knop-Schneickert, E,  et al. 2001Pharmaceutical care services for asthma patients: a controlled intervention studyJ Clin Pharmacol4166876CrossRefPubMedGoogle Scholar
  17. 17.
    Narhi, U, Airaksinen, M, Enlund, H 2002Pharmacists solving problems in asthma management – experiences from a one-year intervention programme in FinlandInt J Pharm Pract10559Google Scholar
  18. 18.
    Weinberger, M, Murray, MD, Marrero, DG, Brewer, N, Lykens, M, Harris, LE,  et al. 2002Effectiveness of pharmacist care for patients with reactive airways disease, a randomized controlled trialJAMA2881594602CrossRefPubMedGoogle Scholar
  19. 19.
    McLean, W, Gillis, J, Waller, R 2003The BC community pharmacy asthma studyCan Respir J10195202PubMedGoogle Scholar
  20. 20.
    Monster, TBM, Janssen, WMT, Jong, PE, DeJong-vanden Berg, LTW 2002Pharmacy data in epidemiological studies: an easy to obtain and reliable toolPharmacoepidemiol Drug Saf1137984CrossRefPubMedGoogle Scholar
  21. 21.
    Lau, HS, Boer, A, Beuning, KS, Porsius, A 1997Validation of pharmacy records in drug exposure assessmentJ Clin Epidemiol5061925CrossRefPubMedGoogle Scholar
  22. 22.
    Essink, RTGM, Vanden Hoff, OP, Koper, JF, Smet, PAGM 2001Wie wel, wie niet? CARA CHECK searches voor extra zorg (Selecting asthma/COPD patients. Searches for extra care)Pharm Weekbl1365949Google Scholar
  23. 23.
    Akkerveeken, HM, Kelder, O, Stuijt, CCM, Vander Wolf, JW, Buurma, H, Gerrits, CMJM 2000Inhalatiecorticosteroiden plus langwerkende beta-2 agonisten. Een gewenste combinatie (A desirable combination. Inhalation corticosteroids plus long-acting beta-2 sympathicomimetics)Pharm Weekbl1359114Google Scholar
  24. 24.
    Geers, H, Pot, HM, Overmars-vander Weij, WCK, Gerrits, CMJM, Buurma, H 2001De standaard en de praktijk. Gebruik van inhalatiecorticosteroiden bij chronisch astma (Standard and practice. Use of inhaled corticosteroids in chronic asthma)Pharm Weekbl13626670Google Scholar
  25. 25.
    Mil, JWF, Dudokvan Heel, MC, Boersma, M, Tromp, TFJ 2001Interventions and documentation for drug-related problems in Dutch community pharmaciesAm J Health-Syst Pharm58142831PubMedGoogle Scholar
  26. 26.
    Anonymous. A framework for development and evaluation of RCTs for complex interventions to improve health. http://www.mrc.ac.uk (last visited April 2005).
  27. 27.
    Stuurman-Bieze, AGG, Kokenberg, MEAP, Tobi, H, Boer, WO, Doormaal, JE, Jong- van den Berg, LTW,  et al. 2005Complex pharmaceutical care intervention in pulmonary care. Part B: Patient opinion and process surveyPharm World Sci2738592Google Scholar
  28. 28.
    Stuurman-Bieze, AGG, Vanden Berg, PB, Tromp, TFJ, DeJong-vanden Berg, LTW 2004Computer-assisted medication review for asthmatic patients in community pharmacies as a basis for an interventionPharm World Sci2628996CrossRefPubMedGoogle Scholar
  29. 29.
    http://www.qipc.nl → onderzoek →IPMP (last visited April 2005)
  30. 30.
    Anonymous. NODE inhaler technique protocols. Kampen, The Netherlands: Quality Institute for Pharmaceutical Care, 2000Google Scholar
  31. 31.
    Gallefos, F, Bakke, PS 1999How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?Am J Respir Crit Care Med16020005Google Scholar
  32. 32.
    Cote, J, Bowie, DM, Robichaud, P, Parent, JG, Battisti, L, Boulet, LP 2001Evaluation of two different educational interventions for adult patients consulting with an acute asthma exacerbationAm J Respir Crit Care Med16314159PubMedGoogle Scholar
  33. 33.
    Stuurman-Bieze, AGG, Booij, AD, Boer, WO, Sonderen, C, Tromp, TFJ 2003Techniek en training leiden tot het doel. Hordelopen bij pro-actieve farmaceutische patiëntenzorg [Skills and training lead to the finish]Pharm Weekbl138112934Google Scholar
  34. 34.
    Knoell, DL, Pierson, JF, Marsh, CB, Allen, JN, Pathak, DS 1998Measurement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinicPharmacotherapy18136575PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Ada G. G. Stuurman-Bieze
    • 1
    • 2
    • 3
    Email author
  • Willem O. de Boer
    • 1
  • Mirjam E. A. P. Kokenberg
    • 1
  • Jacqueline G. Hugtenburg
    • 4
  • Lolkje T. W. de Jong-van den Berg
    • 2
  • Th. F. J. Tromp
    • 1
  1. 1.Quality Institute for Pharmaceutical CareKampenThe Netherlands
  2. 2.Department of Social Pharmacy, Pharmacoepidemiology and PharmacotherapyGroningen University Institute for Drug Exploration (GUIDE)GroningenThe Netherlands
  3. 3.Apotheek WittesteijnEmmeloordThe Netherlands
  4. 4.Apotheek WestwijkAmstelveenThe Netherlands

Personalised recommendations